You are here: Industry Insights > ArisGlobal

News List

The FDA Goes Live with LifeSphere MultiVigilance, Modernizing Pharmacovigilance Capabilities with FAERS II AmericanPharmaceuticalReview
December 16, 2021
ArisGlobal, a provider of life sciences software that automates core drug development with its end-to-end drug development technology platform LifeSphere®, announced the go-live of the FDA Adverse Event Reporting System (FAERS II), an electronic safety...
Suzhou Ribo Life Science Co. Ltd. Adopts ArisGlobal's LifeSphere® MultiVigilance to Advance Data Management from Clinical Trials prnasia
November 01, 2021
ArisGlobal, the leading provider of life sciences software that automates core drug development with its end-to-end drug development technology platform LifeSphere® today announced its partnership...
Major Tobacco Manufacturer Selects ArisGlobal's LifeSphere® MultiVigilance to Automate All Global Internal Adverse Event Management Processes prnasia
February 12, 2020
ArisGlobal, the leading provider of life sciences software that automates core drug development functions for over 250 life sciences companies, today announced one of the world's largest tobacco manufacturing companies has selected LifeSphere® MultiVigila
APCER Life Sciences, ArisGlobal launch integrated PV cloud and services platform financialexpress
June 29, 2018
Best of breed PV services and technology platform will redefine regulatory compliance speed, cost and analytical insight paradigm